These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19258641)
1. Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention. Kereiakes DJ J Invasive Cardiol; 2009 Mar; 21(3):110-3. PubMed ID: 19258641 [No Abstract] [Full Text] [Related]
2. Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Young JJ J Invasive Cardiol; 2005 Jun; 17(6):300-1. PubMed ID: 16003003 [No Abstract] [Full Text] [Related]
3. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
4. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. De Luca G; Suryapranata H; Stone GW; Antoniucci D; Tcheng JE; Neumann FJ; Bonizzoni E; Topol EJ; Chiariello M J Am Coll Cardiol; 2006 Feb; 47(3):685-6. PubMed ID: 16458158 [No Abstract] [Full Text] [Related]
5. The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide. Moliterno DJ; Ziada KM J Am Coll Cardiol; 2008 Feb; 51(5):536-7. PubMed ID: 18237681 [No Abstract] [Full Text] [Related]
6. The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? Brener SJ J Am Coll Cardiol; 2009 May; 53(18):1674-6. PubMed ID: 19406343 [No Abstract] [Full Text] [Related]
7. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty]. Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204 [TBL] [Abstract][Full Text] [Related]
8. Contemporary use of antiplatelet therapies in percutaneous coronary interventions. Saw J; Moliterno DJ Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902 [No Abstract] [Full Text] [Related]
12. In the era of stabilize and seal, is there a role for GP IIb/IIIa agents in PCI? Gilchrist IC Catheter Cardiovasc Interv; 2010 May; 75(6):903-4. PubMed ID: 20432396 [No Abstract] [Full Text] [Related]
13. Comparison of angioplasty with stenting in acute myocardial infarction. Herrmann HC N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478 [No Abstract] [Full Text] [Related]
14. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation]. Radke PW; Schunkert H Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S204-7. PubMed ID: 17109249 [No Abstract] [Full Text] [Related]
16. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta SR; J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860 [TBL] [Abstract][Full Text] [Related]
17. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time. Aquilina M; Varani E; Balducelli M; Vecchi G; Frassineti V; Maresta A J Invasive Cardiol; 2009 Mar; 21(3):115-20. PubMed ID: 19258642 [TBL] [Abstract][Full Text] [Related]
18. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318 [TBL] [Abstract][Full Text] [Related]
19. ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. Boden WE; Hoekstra J; Miller CD Am J Emerg Med; 2008 Feb; 26(2):212-20. PubMed ID: 18272105 [TBL] [Abstract][Full Text] [Related]
20. A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. Gurm HS; Tamhane U; Meier P; Grossman PM; Chetcuti S; Bates ER Circ Cardiovasc Interv; 2009 Jun; 2(3):230-6. PubMed ID: 20031720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]